drugset / Trial / NCT00006254
VNP20009 in Treating Patients With Advanced Solid Tumors
Treatment
Summary
RATIONALE: Biological therapies such as VNP20009 use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I trial to study the effectiveness of VNP20009 in treating patients who have advanced solid tumors.
Timeline
- Start
- 2000-05
- Primary completion
- —
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VNP20009 | Other / unclassified | — | Intravenous |